ZyVersa Therapeutics enters a $10 million share purchase agreement with Williamsburg Venture Holdings to advance kidney disease treatment development. ZyVersa Therapeutics, Inc. has announced a share ...
WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment ...
Logistic Properties of the Americas ( ($LPA) ) has issued an announcement. On September 23, 2025, Logistic Properties of the Americas entered into ...
VANCOUVER, BC, Sept. 12, 2025 /PRNewswire/ - NameSilo Technologies Corp. (CSE: URL) (PINKSHEETS: URLOF) (the "Company") is pleased to announce that it has entered into a definitive share purchase ...
DeFi Development Corp. (Nasdaq: DFDV), the first public U.S. company with a treasury strategy focused on accumulating Solana (SOL), has announced a share purchase agreement with RK Capital Management ...
An update from Envoy Medical ( ($COCH) ) is now available. On September 22, 2025, Envoy Medical announced a Securities Purchase Agreement with ...
With reference to the stock exchange announcement of 3 September 2025, Hafnia Limited (“Hafnia“, the “Company“, OSE ticker code: “HAFNI“, NYSE ticker code: “HAFN”) today announces that it has entered ...
Tharimmune, Inc. (NASDAQ:THAR) shares are trading lower Tuesday after the company announced it has entered into a $5.3 million securities purchase agreement. What To Know: Tharimmune said it entered ...